Neoadjuvant radiotherapy combined with targeted and immune therapies achieves a pathological complete response in borderline resectable gallbladder cancer: a case report and literature review [0.03%]
新辅助放疗联合靶向及免疫治疗使可切除边缘的胆囊癌患者达到病理完全缓解：1例报告及文献复习
Tao Li,Zhiqin Li,Keren Li et al.
Tao Li et al.
Background: Gallbladder cancer, a malignant tumor with a notable prevalence, is primarily treated with surgical R0 resection, which remains the most efficacious therapeutic strategy. Achieving this level of resection is p...
A deep learning aided bone marrow segmentation of quantitative fat MRI for myelofibrosis patients [0.03%]
助力深度学习的骨髓分割定量脂肪MRI以研究骨髓纤维化患者病情
Humera Tariq,Lubomir Hadjiiski,Dariya Malyarenko et al.
Humera Tariq et al.
Purpose: To automate bone marrow segmentation within pelvic bones in quantitative fat MRI of myelofibrosis (MF) patients using deep-learning (DL) U-Net models. ...
Hotspots and frontiers of the relationship between gastric cancer and cancer-associated fibroblasts: a bibliometric analysis [0.03%]
基于文献计量的胃癌相关癌症相关成纤维细胞研究热点及前沿分析
Xiangcheng Hu,Lingling Ren,Shuyuan Zhu et al.
Xiangcheng Hu et al.
Background: Cancer-Associated Fibroblasts (CAFs) are pivotal stromal constituents within the Tumor Microenvironment (TME), characterized by marked heterogeneity and plasticity. Over the past two decades, a notable associa...
Clinical prognosis evaluation of alpha-fetoprotein-positive gastric cancer: comprehensive analysis and development of a novel nomogram for survival prediction [0.03%]
甲胎蛋白阳性胃癌临床预后评估及生存预测列线图模型的建立与验证
Fei Zuo,Yunyan Tan,Wenjun Mao et al.
Fei Zuo et al.
Background: Alpha-fetoprotein (AFP) is an established biomarker for liver cancer, but its role in gastric cancer (GC) remains unclear. This study evaluated AFP's prognostic value in GC and developed a survival prediction ...
Case Report: A case of new-onset retroperitoneal aggressive fibromatosis after resection of solid pseudopapillary tumor of the pancreas and review of the literature [0.03%]
病例报告：胰腺实性假乳头状瘤切除术后并发腹膜后侵袭性纤维瘤病一例及文献复习
Yibo Wang,Hengyu Liu,Ang Li et al.
Yibo Wang et al.
Aggressive fibromatosis is a rare tumor known for its intensive local invasion and postoperative recurrence. Tumors may occur incidentally or be associated with familial adenomatous polyposis. We report a case of new aggressive fibromatosis...
The pivotal role of tertiary lymphoid structures in the tumor immune microenvironment [0.03%]
三级淋巴组织在肿瘤免疫微环境中的核心作用
Chengsen Liu,Jiandong Cao
Chengsen Liu
Tertiary lymphoid structures (TLS) are ectopic lymphoid structures that form in non-lymphoid tissues in response to chronic inflammatory stimulation. Structurally and functionally resembling lymph nodes, TLS are primarily composed of B cell...
Combining immunotherapy with radiotherapy for glioblastoma: recent advances and challenges [0.03%]
免疫治疗与放射治疗结合用于胶质母细胞瘤的最新进展和挑战
Yuanyang Sun,Yun Wang,Shukun Mu et al.
Yuanyang Sun et al.
Glioblastoma (GBM) is an extremely aggressive brain tumor. Its standard treatment currently involves surgery followed by radiotherapy and temozolomide. However, recurrence is frequently unavoidable, and the effect of various treatments is n...
Breast cancer metastases to the stomach with endoscopic submucosal dissection: a case report and literature study [0.03%]
乳腺癌胃转移的内镜下粘膜下剥离术1例报告及文献复习
Qingmiao Zhao,Lizhou Dou,Xiaolong Feng et al.
Qingmiao Zhao et al.
Breast cancer (BC) is the second leading cause of cancer-related death in women, with mortality primarily associated with metastasis. Although gastric metastasis is rare, there are still case reports in the literature. Clinical symptoms of ...
CD46 TREM1 regulates the autophagy marker LC3B ATG5 in oral squamous cell carcinoma [0.03%]
CD46 TREM1调节口腔鳞状细胞癌的自噬标记LC3B ATG5
Xiaodan Liu,Fumin Zheng,Meihua Gao et al.
Xiaodan Liu et al.
Objective: This study aims to explore the regulatory effect of abnormal expression of CD46 and TREM1 on LC3B and ATG5 and to provide new targets for the molecular mechanism and treatment of OSCC. ...
Editorial: EGFR-TKIs for lung cancer treatment: development, application, and side effects [0.03%]
表二元论：EGFR-TKIs用于肺癌治疗：发展、应用和副作用
Qinglin Shen,Hexiao Tang,Shengxi Chen
Qinglin Shen